ERBB2 and neoplasm: In conclusion, our findings indicate that bystander killing in the context of CD3xHER2 bsAbs involves initial bsAb‐mediated T‐cell cytotoxicity against HER2+ tumor areas and subsequent paracrine killing of HER2− tumor areas through IFNγ and TNFα production by the activated T‐cells.